Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Treace Medical Concepts
TMCI
Treace Medical Concepts
Aging Population And Obesity Will Transform Foot Surgery
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
07 Aug 25
Updated
21 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$12.00
37.8% undervalued
intrinsic discount
21 Aug
US$7.47
1Y
18.9%
7D
6.1%
Loading
1Y
18.9%
7D
6.1%
Author's Valuation
US$12.0
37.8% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$12.0
37.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-62m
287m
2019
2021
2023
2025
2027
2028
Revenue US$287.3m
Earnings US$35.7m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
8.95%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.79%
Calculation
US$35.68m
Earnings '28
x
27.41x
PE Ratio '28
=
US$977.98m
Market Cap '28
US$977.98m
Market Cap '28
/
65.88m
No. shares '28
=
US$14.85
Share Price '28
US$14.85
Share Price '28
Discounted to 2025 @ 7.83% p.a.
=
US$11.84
Fair Value '25